Clinical Implications of “Tailored” Antiplatelet Therapy in Patients With Chronic Total Occlusion

BACKGROUND: Clopidogrel nonresponsiveness is a prognostic marker after percutaneous coronary intervention. Prasugrel and ticagrelor provide a better platelet inhibition and represent the first‐line antiplatelet treatment in acute coronary syndrome. We sought to assess the prognostic impact of high p...

Descripción completa

Detalles Bibliográficos
Autores principales: De Gregorio, Maria Grazia, Marcucci, Rossella, Migliorini, Angela, Gori, Anna Maria, Giusti, Betti, Vergara, Ruben, Paniccia, Rita, Carrabba, Nazario, Marchionni, Niccolò, Valenti, Renato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070214/
https://www.ncbi.nlm.nih.gov/pubmed/32067582
http://dx.doi.org/10.1161/JAHA.119.014676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070214/
https://www.ncbi.nlm.nih.gov/pubmed/32067582
http://dx.doi.org/10.1161/JAHA.119.014676

Ejemplares similares